CVS Health Corporation (CVS) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
Revenue Growth Metrics
Revenue Breakdown (FY 2025)
CVS's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
CVS Revenue Analysis (2014–2025)
As of March 2, 2026, CVS Health Corporation (CVS) generated trailing twelve-month (TTM) revenue of $402.07 billion, reflecting solid growth of +8.2% year-over-year. The most recent quarter (Q4 2025) recorded $105.69 billion in revenue, up 2.7% sequentially.
Looking at the longer-term picture, CVS's 5-year compound annual growth rate (CAGR) stands at +8.4%, indicating steady revenue expansion. The company achieved its highest annual revenue of $402.07 billion in 2025, representing a new all-time high.
Revenue diversification analysis shows CVS's business is primarily driven by Pharmacy Revenue (59%), Premiums (35%), and Front Store Revenue (6%). With over half of revenue concentrated in Pharmacy Revenue, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including UNH (+11.8% YoY), and CI (+15.3% YoY), CVS has underperformed the peer group in terms of revenue growth. Compare CVS vs UNH →
Peer Comparison
Compare CVS's revenue metrics with industry peers
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| CVSCurrent | $402.1B | +8.2% | +8.4% | 2.6% | |
| UNH | $447.6B | +11.8% | +11.7% | 4.2% | |
| CI | $247.1B | +15.3% | +10.0% | 3.8% |
Historical Revenue Data
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $402.07B | +7.8% | $55.36B | 13.8% | $10.38B | 2.6% |
| 2024 | $372.81B | +4.2% | $51.40B | 13.8% | $8.52B | 2.3% |
| 2023 | $357.78B | +10.9% | $54.43B | 15.2% | $13.74B | 3.8% |
| 2022 | $322.47B | +10.4% | $54.50B | 16.9% | $7.95B | 2.5% |
| 2021 | $292.11B | +8.7% | $52.12B | 17.8% | $13.31B | 4.6% |
| 2020 | $268.71B | +4.6% | $49.05B | 18.3% | $13.91B | 5.2% |
| 2019 | $256.78B | +32.0% | $45.53B | 17.7% | $11.99B | 4.7% |
| 2018 | $194.58B | +5.3% | $31.54B | 16.2% | $4.02B | 2.1% |
| 2017 | $184.79B | +4.1% | $28.53B | 15.4% | $9.54B | 5.2% |
| 2016 | $177.55B | +15.8% | $28.83B | 16.2% | $10.39B | 5.8% |
See CVS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CVS Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare CVS vs AGIO
See how CVS stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is CVS's revenue growth accelerating or slowing?
CVS maintains +8.2% revenue growth, in line with its 5-year CAGR of +8.4%. TTM revenue stands at $402.1B. Growth rate remains consistent with historical average.
What is CVS's long-term revenue growth rate?
CVS Health Corporation's 5-year revenue CAGR of +8.4% reflects the sustained expansion pattern. Current YoY growth of +8.2% is near this long-term average.
How is CVS's revenue distributed by segment?
CVS reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.